Gene · 2296
Papers3,080
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,080
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathology and new insights in central nervous system lymphomas. | Curr Opin Oncol | 2023 | 37439536 | PubTator, text mining | PubMed |
| LPS binding protein and activation signatures are upregulated during asthma exacerbations in children. | Respir Res | 2023 | 37438758 | PubTator, text mining | PubMed |
| Runt-related Transcription Factors and Gene Regulatory Mechanisms in Skeletal Development and Diseases. | Curr Osteoporos Rep | 2023 | 37436583 | PubTator, text mining | PubMed |
| Case report: Extending the spectrum of clinical and molecular findings in FOXC1 haploinsufficiency syndrome. | Front Genet | 2023 | 37424725 | PubTator, text mining | PubMed |
| Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers. | Nat Commun | 2023 | 37419892 | PubTator, text mining | PubMed |
| Analysis of pathogenic variants in 605 Chinese children with non-syndromic cardiac conotruncal defects based on targeted sequencing. | Genomics | 2023 | 37406974 | PubTator, text mining | PubMed |
| Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I-III lung adenocarcinoma. | Genes Dis | 2023 | 37397559 | PubTator, text mining | PubMed |
| Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer. | World J Surg Oncol | 2023 | 37391802 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals cellular heterogeneity and macrophage-to-mesenchymal transition in bicuspid calcific aortic valve disease. | Biol Direct | 2023 | 37391760 | PubTator, text mining | PubMed |
| Elevated Intraocular Pressure and Glaucomatous Optic Neuropathy: Genes to Disease Mechanisms, Therapeutic Drugs, and Gene Therapies. | Pharmaceuticals (Basel) | 2023 | 37375817 | PubTator, text mining | PubMed |
| A Gene-Based Algorithm for Identifying Factors That May Affect a Speaker's Voice. | Entropy (Basel) | 2023 | 37372241 | PubTator, text mining | PubMed |
| MiR-138-5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B. | Transl Oncol | 2023 | 37364333 | PubTator, text mining | PubMed |
| Loss of function of GATA3 regulates FRA1 and c-FOS to activate EMT and promote mammary tumorigenesis and metastasis. | Cell Death Dis | 2023 | 37353480 | PubTator, text mining | PubMed |
| Long non‑coding RNAs as potential therapeutic targets in non‑small cell lung cancer (Review). | Int J Mol Med | 2023 | 37350412 | PubTator, text mining | PubMed |
| Study of kaempferol in the treatment of COVID-19 combined with Chikungunya co-infection by network pharmacology and molecular docking technology. | Inform Med Unlocked | 2023 | 37346467 | PubTator, text mining | PubMed |
| Identification and bioinformatic analysis of CircRNAs in the plasma of patients with very severe chronic obstructive pulmonary disease. | BMC Pulm Med | 2023 | 37328740 | PubTator, text mining | PubMed |
| TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation. | Int J Biol Sci | 2023 | 37324936 | PubTator, text mining | PubMed |
| Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis. | Front Oncol | 2023 | 37324026 | PubTator, text mining | PubMed |
| HCV Core Protein-ISX Axis Promotes Chronic Liver Disease Progression via Metabolic Remodeling and Immune Suppression. | Adv Sci (Weinh) | 2023 | 37316966 | PubTator, text mining | PubMed |
| Novel maternal duplication of 6p22.3-p25.3 with subtelomeric 6p25.3 deletion: new clinical findings and genotype-phenotype correlations. | Mol Cytogenet | 2023 | 37303060 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2296/papers?page=23